Regression methods for cost-effectiveness analysis with censored data

被引：69
|
作者：
Willan, AR
Lin, DY
Manca, A
机构：
[1] Hosp Sick Children, Program Populat Hlth Sci, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[3] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[4] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
来源：
STATISTICS IN MEDICINE | 2005年 / 24卷 / 01期
关键词：
regression; censored data; cost-effectiveness; incremental net benefit; inverse probability weighting;
D O I：
10.1002/sim.1794
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [21] Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data
    Wang, HK
    Zhao, HW
    BIOMETRICS, 2006, 62 (02) : 570 - 575
  • [22] Cost-effectiveness analysis methods for the REACT study
    Duren-Winfield, V
    Berry, MJ
    Jones, SA
    Clark, DH
    Sevick, MA
    WESTERN JOURNAL OF NURSING RESEARCH, 2000, 22 (04) : 460 - 474
  • [23] A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost-Effectiveness Analysis
    Djalalov, Sandjar
    Beca, Jaclyn
    Ewara, Emmanuel M.
    Hoch, Jeffrey S.
    PHARMACOECONOMICS, 2019, 37 (12) : 1525 - 1536
  • [24] Issues in the Analysis of Longitudinal Cost-effectiveness Data
    Wetzelaer, Pim
    Arntz, Arnoud
    Evers, Silvia M. A. A.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2013, 16 : S38 - S38
  • [25] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [26] Cost-effectiveness of surveillance methods
    Dettenkofer, M
    Daschner, FD
    BAILLIERES CLINICAL INFECTIOUS DISEASES, 1996, 3 (02): : 289 - 301
  • [27] Methods for cost-effectiveness study
    Benning, TL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 109 (03) : 357 - 357
  • [28] Bayesian cost-effectiveness analysis: Illustration of methods.
    Fryback, DG
    Chinnis, JO
    Uvila, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 484 - 484
  • [29] METHODS OF COST-EFFECTIVENESS ANALYSIS - AREAS OF CONSENSUS AND DEBATE
    LUCE, BR
    SIMPSON, K
    CLINICAL THERAPEUTICS, 1995, 17 (01) : 109 - 125
  • [30] Cost-Effectiveness Analysis of Selected Methods of Haemostatis Evaluation
    Zavadil, Martin
    Blahynkova, Michaela
    Selcan, Miroslav
    Rogalewicz, Vladimir
    XV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING - MEDICON 2019, 2020, 76 : 1085 - 1090
12345